Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine-resistant breast cancer
Joanna Achinger-Kawecka, Fátima Valdés‐Mora, Phuc‐Loi Luu, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 143

Showing 1-25 of 143 citing articles:

Breast Cancer: A Molecularly Heterogenous Disease Needing Subtype-Specific Treatments
Ugo Testa, Germana Castelli, Elvira Pelosi
Medical Sciences (2020) Vol. 8, Iss. 1, pp. 18-18
Open Access | Times Cited: 166
Sex hormone fluctuation and increased female risk for depression and anxiety disorders: From clinical evidence to molecular mechanisms
Marija Kundaković, Devin Rocks
Frontiers in Neuroendocrinology (2022) Vol. 66, pp. 101010-101010
Open Access | Times Cited: 159
Subtype-specific 3D genome alteration in acute myeloid leukaemia
Jie Xu, Fan Song, Huijue Lyu, et al.
Nature (2022) Vol. 611, Iss. 7935, pp. 387-398
Open Access | Times Cited: 128
Multiomics in primary and metastatic breast tumors from the AURORA US network finds microenvironment and epigenetic drivers of metastasis
Susana García‐Recio, Toshinori Hinoue, Gregory Wheeler, et al.
Nature Cancer (2022)
Open Access | Times Cited: 80
Epigenetic and breast cancer therapy: Promising diagnostic and therapeutic applications
Gulab Sher, Nadia Aziz Salman, Abdul Quaiyoom Khan, et al.
Seminars in Cancer Biology (2020) Vol. 83, pp. 152-165
Open Access | Times Cited: 78
Cancer epigenetics: Past, present and future
Jae Eun Lee, Mi‐Young Kim
Seminars in Cancer Biology (2021) Vol. 83, pp. 4-14
Closed Access | Times Cited: 72
Mapping genomic and epigenomic evolution in cancer ecosystems
Toshikazu Ushijima, Susan J. Clark, Patrick Tan
Science (2021) Vol. 373, Iss. 6562, pp. 1474-1479
Closed Access | Times Cited: 64
Androgen receptor and MYC equilibration centralizes on developmental super-enhancer
Haiyang Guo, Yiming Wu, Mannan Nouri, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 62
ESR1 mutant breast cancers show elevated basal cytokeratins and immune activation
Zheqi Li, Olivia McGinn, Yang Wu, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 54
Characterisation and reproducibility of the HumanMethylationEPIC v2.0 BeadChip for DNA methylation profiling
Timothy J. Peters, Braydon Meyer, Lauren Ryan, et al.
BMC Genomics (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 14
Sex-specific genetic architecture of blood pressure
Min‐Lee Yang, Chang Xu, Trisha Gupte, et al.
Nature Medicine (2024) Vol. 30, Iss. 3, pp. 818-828
Closed Access | Times Cited: 13
The potential of epigenetic therapy to target the 3D epigenome in endocrine-resistant breast cancer
Joanna Achinger-Kawecka, Clare Stirzaker, Neil Portman, et al.
Nature Structural & Molecular Biology (2024) Vol. 31, Iss. 3, pp. 498-512
Open Access | Times Cited: 12
FOXF2 expression triggered by endocrine therapy orchestrates therapeutic resistance through reorganization of chromatin architecture in breast cancer
Rui Zhang, Wen-Jing Jiang, Shuai Zhao, et al.
Cancer Letters (2025), pp. 217463-217463
Closed Access | Times Cited: 1
Mechanisms of Resistance to Chemotherapy in Breast Cancer and Possible Targets in Drug Delivery Systems
Patrícia de Faria Lainetti, Antonio Fernando Leis‐Filho, Renée Laufer Amorim, et al.
Pharmaceutics (2020) Vol. 12, Iss. 12, pp. 1193-1193
Open Access | Times Cited: 55
DNA methylation is required to maintain both DNA replication timing precision and 3D genome organization integrity
Qian Du, Grady C. Smith, Phuc‐Loi Luu, et al.
Cell Reports (2021) Vol. 36, Iss. 12, pp. 109722-109722
Open Access | Times Cited: 53
Understanding the Mechanisms by Which Epigenetic Modifiers Avert Therapy Resistance in Cancer
Anthony Quagliano, Anilkumar Gopalakrishnapillai, Sonali P. Barwe
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 51
Histone acetylation dynamics modulates chromatin conformation and allele-specific interactions at oncogenic loci
Stéphanie Sungalee, Yuanlong Liu, Ruxandra A. Lambuta, et al.
Nature Genetics (2021) Vol. 53, Iss. 5, pp. 650-662
Open Access | Times Cited: 49
Organ Tropism in Solid Tumor Metastasis: An Updated Review
Keywan Mortezaee
Future Oncology (2021) Vol. 17, Iss. 15, pp. 1943-1961
Closed Access | Times Cited: 46
Sex-Bias in Irritable Bowel Syndrome: Linking Steroids to the Gut-Brain Axis
Sik Yu So, Tor Savidge
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 42
EWS/FLI mediated reprogramming of 3D chromatin promotes an altered transcriptional state in Ewing sarcoma
Iftekhar A. Showpnil, Julia Selich‐Anderson, Cenny Taslim, et al.
Nucleic Acids Research (2022) Vol. 50, Iss. 17, pp. 9814-9837
Open Access | Times Cited: 38
Super-enhancer-controlled positive feedback loop BRD4/ERα–RET–ERα promotes ERα-positive breast cancer
Zaozao Zheng, Lin Xia, Guo‐sheng Hu, et al.
Nucleic Acids Research (2022) Vol. 50, Iss. 18, pp. 10230-10248
Open Access | Times Cited: 32
Epigenetic Therapies and Biomarkers in Breast Cancer
Lauren Brown, Joanna Achinger-Kawecka, Neil Portman, et al.
Cancers (2022) Vol. 14, Iss. 3, pp. 474-474
Open Access | Times Cited: 31
Epigenetic deregulation in breast cancer microenvironment: Implications for tumor progression and therapeutic strategies
Lenka Trnkova, Verona Buociková, Michal Mego, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 174, pp. 116559-116559
Open Access | Times Cited: 7
Genome-Wide Estrogen Receptor Activity in Breast Cancer
Anca M. Farcas, Sankari Nagarajan, Sabina Cosulich, et al.
Endocrinology (2020) Vol. 162, Iss. 2
Open Access | Times Cited: 45
Crosstalk between microRNA expression and DNA methylation drives the hormone-dependent phenotype of breast cancer
Miriam R. R. Aure, Thomas Fleischer, Sunniva Bjørklund, et al.
Genome Medicine (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 41
Page 1 - Next Page

Scroll to top